feed,title,long_url,short_url
Benzinga,"Harpoon's TriTAC Programs Show Reduction in Tumor Size, Stable Disease Across Solid Tumors",https://benzinga.com/general/biotech/21/06/21446975/harpoons-tritac-programs-show-reduction-in-tumor-size-stable-disease-across-solid-tumors,https://j.mp/3v3SDdf
Benzinga,Amgen's Sotorasib is First KRAS Inhibitor to Show Overall Survival Benefit in Lung Cancer With KRAS Mutations,https://benzinga.com/general/biotech/21/06/21446754/amgens-sotorasib-is-first-kras-inhibitor-to-show-overall-survival-benefit-in-lung-cancer-with-kra,https://j.mp/3ckJCpF
